A detailed history of Diametric Capital, LP transactions in Surmodics Inc stock. As of the latest transaction made, Diametric Capital, LP holds 7,500 shares of SRDX stock, worth $312,075. This represents 0.11% of its overall portfolio holdings.

Number of Shares
7,500
Previous 20,000 62.5%
Holding current value
$312,075
Previous $594,000 62.29%
% of portfolio
0.11%
Previous 0.4%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$29.0 - $38.0 $362,500 - $475,000
-12,500 Reduced 62.5%
7,500 $224,000
Q2 2025

Aug 13, 2025

BUY
$26.76 - $31.1 $535,200 - $622,000
20,000 New
20,000 $594,000
Q4 2024

Feb 12, 2025

BUY
$37.5 - $40.13 $362,212 - $387,615
9,659 Added 89.62%
20,437 $809,000
Q2 2024

Aug 13, 2024

BUY
$25.39 - $42.1 $273,653 - $453,753
10,778 New
10,778 $453,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $583M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Diametric Capital, LP Portfolio

Follow Diametric Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Diametric Capital, LP with notifications on news.